↓ Skip to main content

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

Overview of attention for article published in Cardiovascular Diabetology, January 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
157 Mendeley